1	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
2	regulates	regulate	_	_	_	_	_	_	_
3	Fas/APO-1/CD95-	fas/apo-1/cd95-	_	_	_	_	_	_	_
4	and	and	_	_	_	_	_	_	_
5	TCR-	tcr-	_	_	_	_	_	_	_
6	mediated	mediate	_	_	_	_	_	_	_
7	apoptosis	apoptosis	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	T	t	_	_	_	_	_	_	_
10	lymphocytes	lymphocyte	_	_	_	_	_	_	_
11	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	maintenance	maintenance	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	lymphocyte	lymphocyte	_	_	_	_	_	_	_
5	homeostasis	homeostasis	_	_	_	_	_	_	_
6	by	by	_	_	_	_	_	_	_
7	apoptosis	apoptosis	_	_	_	_	_	_	_
8	is	be	_	_	_	_	_	_	_
9	a	a	_	_	_	_	_	_	_
10	critical	critical	_	_	_	_	_	_	_
11	regulatory	regulatory	_	_	_	_	_	_	_
12	mechanism	mechanism	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	normal	normal	_	_	_	_	_	_	_
16	immune	immune	_	_	_	_	_	_	_
17	system	system	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	transcription	transcription	_	_	_	_	_	_	_
3	factor	factor	_	_	_	_	_	_	_
4	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
5	has	have	_	_	_	_	_	_	_
6	been	be	_	_	_	_	_	_	_
7	shown	show	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	play	play	_	_	_	_	_	_	_
10	a	a	_	_	_	_	_	_	_
11	role	role	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	protecting	protect	_	_	_	_	_	_	_
14	cells	cell	_	_	_	_	_	_	_
15	against	against	_	_	_	_	_	_	_
16	death	death	_	_	_	_	_	_	_
17	mediated	mediate	_	_	_	_	_	_	_
18	by	by	_	_	_	_	_	_	_
19	TNF	TNF	_	_	_	_	_	_	_
20	We	we	_	_	_	_	_	_	_
21	show	show	_	_	_	_	_	_	_
22	here	here	_	_	_	_	_	_	_
23	that	that	_	_	_	_	_	_	_
24	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
25	also	also	_	_	_	_	_	_	_
26	has	have	_	_	_	_	_	_	_
27	a	a	_	_	_	_	_	_	_
28	role	role	_	_	_	_	_	_	_
29	in	in	_	_	_	_	_	_	_
30	regulating	regulate	_	_	_	_	_	_	_
31	Fas/APO-1/CD95-mediated	fas/apo-1/cd95-mediated	_	_	_	_	_	_	_
32	death	death	_	_	_	_	_	_	_
33	,	,	_	_	_	_	_	_	_
34	a	a	_	_	_	_	_	_	_
35	major	major	_	_	_	_	_	_	_
36	pathway	pathway	_	_	_	_	_	_	_
37	of	of	_	_	_	_	_	_	_
38	peripheral	peripheral	_	_	_	_	_	_	_
39	T	t	_	_	_	_	_	_	_
40	cell	cell	_	_	_	_	_	_	_
41	death	death	_	_	_	_	_	_	_
42	.	.	_	_	_	_	_	_	_

1	Transfection	Transfection	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	Jurkat	Jurkat	_	_	_	_	_	_	_
4	cells	cell	_	_	_	_	_	_	_
5	with	with	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
8	subunits	subunit	_	_	_	_	_	_	_
9	p50	p50	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	p65	p65	_	_	_	_	_	_	_
12	confers	confer	_	_	_	_	_	_	_
13	resistance	resistance	_	_	_	_	_	_	_
14	against	against	_	_	_	_	_	_	_
15	Fas-mediated	fas-mediated	_	_	_	_	_	_	_
16	apoptosis	apoptosis	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	Reciprocally	reciprocally	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	inhibition	inhibition	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
6	activation	activation	_	_	_	_	_	_	_
7	by	by	_	_	_	_	_	_	_
8	a	a	_	_	_	_	_	_	_
9	soluble	soluble	_	_	_	_	_	_	_
10	peptide	peptide	_	_	_	_	_	_	_
11	inhibitor	inhibitor	_	_	_	_	_	_	_
12	or	or	_	_	_	_	_	_	_
13	a	a	_	_	_	_	_	_	_
14	dominant	dominant	_	_	_	_	_	_	_
15	form	form	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
19	inhibitor	inhibitor	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	IkappaB	IkappaB	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	makes	make	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	cells	cell	_	_	_	_	_	_	_
26	more	more	_	_	_	_	_	_	_
27	susceptible	susceptible	_	_	_	_	_	_	_
28	to	to	_	_	_	_	_	_	_
29	Fas-mediated	fas-mediated	_	_	_	_	_	_	_
30	apoptosis	apoptosis	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	Furthermore	furthermore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	inhibition	inhibition	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
6	activation	activation	_	_	_	_	_	_	_
7	by	by	_	_	_	_	_	_	_
8	a	a	_	_	_	_	_	_	_
9	soluble	soluble	_	_	_	_	_	_	_
10	peptide	peptide	_	_	_	_	_	_	_
11	inhibitor	inhibitor	_	_	_	_	_	_	_
12	rendered	render	_	_	_	_	_	_	_
13	a	a	_	_	_	_	_	_	_
14	T	t	_	_	_	_	_	_	_
15	cell	cell	_	_	_	_	_	_	_
16	hybridoma	hybridoma	_	_	_	_	_	_	_
17	more	more	_	_	_	_	_	_	_
18	susceptible	susceptible	_	_	_	_	_	_	_
19	to	to	_	_	_	_	_	_	_
20	TCR-mediated	tcr-mediated	_	_	_	_	_	_	_
21	apoptosis	apoptosis	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Correspondingly	correspondingly	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	transfection	transfection	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	p50	p50	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	p65	p65	_	_	_	_	_	_	_
8	provided	provide	_	_	_	_	_	_	_
9	considerable	considerable	_	_	_	_	_	_	_
10	protection	protection	_	_	_	_	_	_	_
11	from	from	_	_	_	_	_	_	_
12	TCR-mediated	tcr-mediated	_	_	_	_	_	_	_
13	apoptosis	apoptosis	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	observations	observation	_	_	_	_	_	_	_
3	were	be	_	_	_	_	_	_	_
4	corroborated	corroborate	_	_	_	_	_	_	_
5	by	by	_	_	_	_	_	_	_
6	studies	study	_	_	_	_	_	_	_
7	on	on	_	_	_	_	_	_	_
8	Fas-mediated	fas-mediated	_	_	_	_	_	_	_
9	death	death	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	primary	primary	_	_	_	_	_	_	_
12	T	t	_	_	_	_	_	_	_
13	cells	cell	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	Concanavalin	Concanavalin	_	_	_	_	_	_	_
2	A-activated	a-activated	_	_	_	_	_	_	_
3	cycling	cycling	_	_	_	_	_	_	_
4	T	t	_	_	_	_	_	_	_
5	cell	cell	_	_	_	_	_	_	_
6	blasts	blast	_	_	_	_	_	_	_
7	from	from	_	_	_	_	_	_	_
8	mice	mouse	_	_	_	_	_	_	_
9	that	that	_	_	_	_	_	_	_
10	are	be	_	_	_	_	_	_	_
11	transgenic	transgenic	_	_	_	_	_	_	_
12	for	for	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	dominant	dominant	_	_	_	_	_	_	_
15	IkappaB	IkappaB	_	_	_	_	_	_	_
16	molecule	molecule	_	_	_	_	_	_	_
17	have	have	_	_	_	_	_	_	_
18	increased	increase	_	_	_	_	_	_	_
19	sensitivity	sensitivity	_	_	_	_	_	_	_
20	to	to	_	_	_	_	_	_	_
21	Fas-mediated	fas-mediated	_	_	_	_	_	_	_
22	apoptosis	apoptosis	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	associated	associate	_	_	_	_	_	_	_
25	with	with	_	_	_	_	_	_	_
26	a	a	_	_	_	_	_	_	_
27	down-regulation	down-regulation	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
30	complexes	complex	_	_	_	_	_	_	_
31	in	in	_	_	_	_	_	_	_
32	the	the	_	_	_	_	_	_	_
33	nucleus	nucleus	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	blocking	block	_	_	_	_	_	_	_
5	TNF	TNF	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	itself	itself	_	_	_	_	_	_	_
8	a	a	_	_	_	_	_	_	_
9	positive	positive	_	_	_	_	_	_	_
10	regulator	regulator	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	with	with	_	_	_	_	_	_	_
15	neutralizing	neutralize	_	_	_	_	_	_	_
16	antibodies	antibody	_	_	_	_	_	_	_
17	renders	render	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	cells	cell	_	_	_	_	_	_	_
20	more	more	_	_	_	_	_	_	_
21	susceptible	susceptible	_	_	_	_	_	_	_
22	to	to	_	_	_	_	_	_	_
23	anti-Fas-mediated	anti-fas-mediated	_	_	_	_	_	_	_
24	apoptosis	apoptosis	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	summary	summary	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	our	our	_	_	_	_	_	_	_
5	results	result	_	_	_	_	_	_	_
6	provide	provide	_	_	_	_	_	_	_
7	compelling	compelling	_	_	_	_	_	_	_
8	evidence	evidence	_	_	_	_	_	_	_
9	that	that	_	_	_	_	_	_	_
10	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
11	protects	protect	_	_	_	_	_	_	_
12	against	against	_	_	_	_	_	_	_
13	Fas-mediated	fas-mediated	_	_	_	_	_	_	_
14	death	death	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	is	be	_	_	_	_	_	_	_
17	likely	likely	_	_	_	_	_	_	_
18	to	to	_	_	_	_	_	_	_
19	be	be	_	_	_	_	_	_	_
20	an	an	_	_	_	_	_	_	_
21	important	important	_	_	_	_	_	_	_
22	regulator	regulator	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	T	t	_	_	_	_	_	_	_
25	cell	cell	_	_	_	_	_	_	_
26	homeostasis	homeostasis	_	_	_	_	_	_	_
27	and	and	_	_	_	_	_	_	_
28	tolerance	tolerance	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

